EP-1522 Radiotherapy with or without antihormonal therapy for PSMA-positive oligorecurrent prostate cancer. (April 2019) - Kroeze, S.; Henkenberens, C.; Schmidt-Hegemann, N.; Vogel, M.; Kirste, S.; Becker, J.; Christiansen, H.; Belka, C.; Combs, S.; Grosu, A.; Müller, A.; Guckenberger, M.